产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 25mg | 99% | 现货 | |||
| 50mg | 99% | 现货 | |||
| 100mg | 99% | 现货 | |||
| 250mg | 99% | 现货 | |||
| 1g | 99% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 25mg | 99% | 现货 | |||
| 50mg | 99% | 现货 | |||
| 100mg | 99% | 现货 | |||
| 250mg | 99% | 现货 | |||
| 1g | 99% | 询价 |
CAS No. |
1570496-34-2 |
|---|---|
中文名称 |
5-(5-甲基-1-(3-(4-(甲基磺酰基)哌啶-1-基)苄基)-1H-1,2,4-三唑-3-基)-3-(4-(三氟甲氧基)苯基)-1,2,4-恶二唑 |
英文名称 |
5-(5-Methyl-1-(3-(4-(methylsulfonyl)piperidin-1-yl)benzyl)-1H-1,2,4-triazol-3-yl)-3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazole |
别名 |
AKOS030527987 | 1570496-34-2 | A936426 | Oxidative phosphorylation inhibitor IACS-010759 | HY-112037 | NSC809972 | NSC-809972 | IACS-010759 free base | 4-Methanesulfonyl-1-{3-[(5-methyl-3-{3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl}-1H-1,2,4-tria |
标准英文名 |
5-(5-methyl-1-(3-(4-(methylsulfonyl)piperidin-1-yl)benzyl)-1H-1,2,4-triazol-3-yl)-3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazole |
MDL No. |
MFCD30489429 |
分子式 |
C25H25F3N6O4S |
分子量 |
562.57 |
精确分子量 |
562.16 |
SMILES |
FC(F)(F)OC1=CC=C(C2=NOC(C3=NN(CC4=CC=CC(N5CCC(S(=O)(C)=O)CC5)=C4)C(C)=N3)=N2)C=C1 |
标准SMILES |
CC1=NC(=NN1CC1C=C(C=CC=1)N1CCC(CC1)S(C)(=O)=O)C1=NC(=NO1)C1C=CC(=CC=1)OC(F)(F)F |
性状 |
Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
HWJWNWZJUYCGKV-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Sealed in dry,Store in freezer, under -20°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A ),Specific target organ toxicity, single exposure;Respiratory system (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|